Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 145

1.

What is new in the therapy of ANCA-associated vasculitides? Take home messages from the 12th workshop on ANCA and systemic vasculitides.

de Groot K, Jayne D.

Clin Nephrol. 2005 Dec;64(6):480-4. Review.

PMID:
16370164
[PubMed - indexed for MEDLINE]
2.

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.

De Groot K, Rasmussen N, Bacon PA, Tervaert JW, Feighery C, Gregorini G, Gross WL, Luqmani R, Jayne DR.

Arthritis Rheum. 2005 Aug;52(8):2461-9.

PMID:
16052573
[PubMed - indexed for MEDLINE]
Free Article
3.

Advances in the therapy of Wegener's granulomatosis.

Hellmich B, Lamprecht P, Gross WL.

Curr Opin Rheumatol. 2006 Jan;18(1):25-32. Review.

PMID:
16344616
[PubMed - indexed for MEDLINE]
4.

[Treatment of ANCA-associated vascularitides].

Guillevin L, Pagnoux C.

Presse Med. 2007 May;36(5 Pt 2):922-7. Epub 2007 Apr 3. Review. French.

PMID:
17408912
[PubMed - indexed for MEDLINE]
5.

Brief Report: long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.

Faurschou M, Westman K, Rasmussen N, de Groot K, Flossmann O, Höglund P, Jayne DR; European Vasculitis Study Group.

Arthritis Rheum. 2012 Oct;64(10):3472-7. doi: 10.1002/art.34547.

PMID:
22614882
[PubMed - indexed for MEDLINE]
Free Article
6.

Use of methotrexate in ANCA-associated vasculitides.

Reinhold-Keller E, de Groot K.

Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 61):S178-82. Epub 2010 Oct 28. Review.

PMID:
21044456
[PubMed - indexed for MEDLINE]
7.

[Diagnosis and management of small vessel vasculitides].

Pettersson T, Karjalainen A.

Duodecim. 2010;126(12):1496-507. Review. Finnish.

PMID:
20617753
[PubMed - indexed for MEDLINE]
8.

A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.

Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniené J, Ekstrand A, Gaskin G, Gregorini G, de Groot K, Gross W, Hagen EC, Mirapeix E, Pettersson E, Siegert C, Sinico A, Tesar V, Westman K, Pusey C; European Vasculitis Study Group.

N Engl J Med. 2003 Jul 3;349(1):36-44.

PMID:
12840090
[PubMed - indexed for MEDLINE]
Free Article
9.

[ANCA-associated vasculitis].

Sinico RA, Sabadini E, Boeri R, Radice A.

G Ital Nefrol. 2002 Mar-Apr;19(2):125-36. Review. Italian.

PMID:
12195410
[PubMed - indexed for MEDLINE]
10.

ANCA-associated vasculitis: diagnostic and therapeutic strategy.

Ozaki S.

Allergol Int. 2007 Jun;56(2):87-96. Epub 2007 May 1. Review.

PMID:
17460438
[PubMed - indexed for MEDLINE]
Free Article
11.

Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis.

Tervaert JW, Stegeman CA, Kallenberg CG.

Curr Opin Nephrol Hypertens. 2001 Mar;10(2):211-7. Review.

PMID:
11224696
[PubMed - indexed for MEDLINE]
12.

Treatment of ANCA-associated vasculitis, where to go?

Kallenberg CG.

Clin Rev Allergy Immunol. 2012 Dec;43(3):242-8. doi: 10.1007/s12016-012-8325-z. Review.

PMID:
22669755
[PubMed - indexed for MEDLINE]
13.

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.

de Groot K, Harper L, Jayne DR, Flores Suarez LF, Gregorini G, Gross WL, Luqmani R, Pusey CD, Rasmussen N, Sinico RA, Tesar V, Vanhille P, Westman K, Savage CO; EUVAS (European Vasculitis Study Group).

Ann Intern Med. 2009 May 19;150(10):670-80.

PMID:
19451574
[PubMed - indexed for MEDLINE]
14.

[Diagnosis und therapy of ANCA-associated vasculitis].

Aries PM, Hellmich B, Gross WL.

Dtsch Med Wochenschr. 2006 Mar 3;131(9):443-6. Review. German.

PMID:
16493569
[PubMed - indexed for MEDLINE]
15.

New treatments of ANCA-associated vasculitis.

Kallenberg CG, Tervaert JW.

Sarcoidosis Vasc Diffuse Lung Dis. 2000 Jun;17(2):125-9. Review.

PMID:
10957760
[PubMed - indexed for MEDLINE]
16.

ANCA-associated vasculitides: pathogenetic aspects and current evidence-based therapy.

Holle JU, Gross WL.

J Autoimmun. 2009 May-Jun;32(3-4):163-71. doi: 10.1016/j.jaut.2009.02.019. Epub 2009 Apr 2. Review.

PMID:
19345067
[PubMed - indexed for MEDLINE]
17.

When should patients with ANCA-associated vasculitis be switched from induction to maintenance therapy?

Flossmann O, de Groot K.

Nat Clin Pract Nephrol. 2007 May;3(5):236-7. No abstract available.

PMID:
17457358
[PubMed - indexed for MEDLINE]
18.

Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.

Hu W, Liu C, Xie H, Chen H, Liu Z, Li L.

Nephrol Dial Transplant. 2008 Apr;23(4):1307-12. Epub 2007 Dec 8.

PMID:
18065810
[PubMed - indexed for MEDLINE]
Free Article
19.

[Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis].

Tervaert JW, Stegeman CA.

Ned Tijdschr Geneeskd. 2003 Nov 15;147(46):2265-7. Dutch.

PMID:
14655291
[PubMed - indexed for MEDLINE]
20.

Mycophenolate mofetil as maintenance therapy in patients with vasculitis and renal involvement.

Iatrou C, Zerbala S, Revela I, Spanou E, Marinaki S, Nakopoulou L, Boletis J.

Clin Nephrol. 2009 Jul;72(1):31-7.

PMID:
19640385
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk